The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...

With age comes wisdom. But you know what else can come with age? Weight gain. Losing weight can also be harder as you grow ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

How long it takes to lose weight can vary based on a number of factors, such as age, medications you take, your activity ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...